We use cookies for a better user experience. Click here to know more about it. 


Global Medical Radioisotopes Grows with CAGR of 4.28% Backed with Rigid Demand - QYResearch Report

Author: QYResearch  |   Published Date: 2021-10-20   |   Views: 60

Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.


The decay product of Mo-99, Tc-99m, is the workhorse isotope in nuclear medicine for diagnostic imaging. Tc-99m is used for the detection of disease and for the study of organ structure and function. Tc-99m is especially useful for nuclear medicine procedures because it can be chemically incorporated into small molecule ligands and proteins that concentrate in specific organs or tissues when injected into the body. Tc-99m is used in more than 40-million diagnostic procedures each year.


Many medical products today are sterilised by gamma rays from a Co-60 source, a technique which generally is much cheaper and more effective than steam heat sterilisation. The disposable syringe is an example of a product sterilised by gamma rays. Because it is a 'cold' process radiation can be used to sterilise a range of heat-sensitive items such as powders, ointments, and solutions, as well as biological preparations such as bone, nerve, and skin to be used in tissue grafts. Large-scale irradiation facilities for gamma sterilisation are installed in many countries. Smaller gamma irradiators, often utilising Cs-137, having a longer half-life, are used for treating blood for transfusions and for other medical applications. Sterilisation by radiation has several benefits. It is safer and cheaper because it can be done after the item is packaged. The sterile shelf-life of the item is then practically indefinite provided the seal is not broken. Apart from syringes, medical products sterilised by radiation include cotton wool, burn dressings, surgical gloves, heart valves, bandages, plastic, and rubber sheets and surgical instruments. Within the United States and other parts of the developed world, the trend has been to reduce the use of Co-60. And many U.S. hospitals have shifted to generating highly energetic beams with accelerator technology for such therapy. But much of the developing world still employs Co-60 mainly because of the capital costs associated with switching to alternative non-radioactive source technologies.


Global Medical Radioisotopes market is valued at USD 583.52 million in 2020 and is expected to reach USD 834.97 million by the end of 2027, growing at a CAGR of 4.28% between 2021 and 2027.

Americas is the largest consumer by regions. Europe is the second largest with 26% market share. Asia Pacific s the following consumption region with 24% consumption market share. While the U.S. produces a significant number of the isotopes used by researchers, industry and the medical community, the U.S. is dependent upon foreign sources for many. Historically the U.S. provided almost all of the isotopes that were required for domestic consumption or, in special cases, acquired them from long-time allies. But beginning in the 1990’s other governments began to view the isotope industry as a high tech growth industry, and subsidized the production and sale of isotopes, targeting U.S. companies. The result is that U.S. industry has been switching its buying from the U.S. and DOE to foreign sources of supply.


Read More Information: https://www.qyresearch.com/


About Us:

QYResearch provides Market Research Reports for clients all over the world. As of now, QYResearch data as following:

62000 + Clients(cover 100% the world strong 500 companies and most industries’ leading players such as TOP5 players)

7800 + Experts(most of them with more than 15 years’ experience in their industry and professional knowledge both in market and technology)

300 + Data Base(40% government related data base, 30% third part data base, 10% international agencies data base, 30% technology and market data base)

2 Million + Reports(cover almost all industries and most detailed products such as product model level research reports, where you can find all what you need in one shop)

1000 + Custom Research Projects(most clients need custom research service and QYResearch keeps offering good and depth service for them)

30 + Roles Data Interview Checking System(only QYResearch uses such interview system with more than 30 roles in order to confirm the data reliability)

13 + Years focus market research and continues to support the client success.


Media Contact:

Rahul Singh - Digital Marketing Director

Contact: +91 7028 920 828   +81-903-800-9273    +86-108-294-5717

Email: rahul@qyresearch.com

Sales Contact US:

USA Registered Office: QY Research, INC.

17890 Castleton, Suite 369,

City of industry, CA - 91748

Phone: +1-626-295-2442

Emails – enquiry@qyrsearch.com

Web – www.qyresearch.com

QYR Clients

  • csl
  • croozer
  • crital alert
  • cristal
  • corveneng
  • coperion
  • contijpi medical
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
More Clients...